Detalhe da pesquisa
1.
Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors.
Acta Neuropathol
; 147(1): 85, 2024 05 17.
Artigo
Inglês
| MEDLINE | ID: mdl-38758238
2.
Different patient versus provider perspectives on living with Cushing's disease.
Pituitary
; 27(2): 141-150, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38315244
3.
A medical chart audit to assess endocrinologist perceptions of the burden of endogenous Cushing's syndrome.
Pituitary
; 27(2): 129-140, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38189862
4.
Patients with hypercortisolemic Cushing disease possess a distinct class of hematopoietic progenitor cells leading to erythrocytosis.
Haematologica
; 108(4): 1053-1067, 2023 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35861015
5.
Medical therapy for refractory pituitary adenomas.
Pituitary
; 26(3): 303-306, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-37115295
6.
Dabrafenib as a diagnostic and therapeutic strategy for the non-surgical management of papillary craniopharyngioma.
Pituitary
; 26(4): 482-487, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-37428397
7.
The treatment of aggressive prolactinomas with everolimus.
Pituitary
; 26(4): 474-481, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-37428396
8.
Evaluating the burden of endogenous Cushing's syndrome using a web-based questionnaire and validated patient-reported outcome measures.
Pituitary
; 26(4): 364-374, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-37074630
9.
Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing's syndrome.
Pituitary
; 24(1): 104-115, 2021 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-33216275
10.
Multidisciplinary management of acromegaly: A consensus.
Rev Endocr Metab Disord
; 21(4): 667-678, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32914330
11.
Predicting malignancy in patients with adrenal tumors using 18 F-FDG-PET/CT SUVmax.
J Surg Oncol
; 122(8): 1821-1826, 2020 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-32914407
12.
Patient reported outcome data from acromegaly patients treated with injectable somatostatin receptor ligands (SRLs) in routine clinical practice.
BMC Endocr Disord
; 20(1): 117, 2020 Jul 31.
Artigo
Inglês
| MEDLINE | ID: mdl-32736547
13.
Observed discordance between outcomes reported by acromegaly patients and their treating endocrinology medical provider.
Pituitary
; 23(2): 140-148, 2020 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-31808101
14.
Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies.
Breast Cancer Res Treat
; 174(1): 15-26, 2019 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-30467659
15.
MIFEPRISTONE TREATMENT FOR MILD AUTONOMOUS CORTISOL SECRETION DUE TO ADRENAL ADENOMAS: A PILOT STUDY.
Endocr Pract
; 25(8): 846-853, 2019 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-31070948
16.
Refractory pituitary adenomas: preface.
Pituitary
; 26(3): 261-262, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37358783
17.
Proinflammatory cytokines remain elevated despite long-term remission in Cushing's disease: a prospective study.
Clin Endocrinol (Oxf)
; 86(1): 68-74, 2017 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-27630017
18.
Follow-up intervals in patients with Cushing's disease: recommendations from a panel of experienced pituitary clinicians.
Pituitary
; 20(4): 422-429, 2017 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-28275992
19.
BIOCHEMICAL CONTROL DURING LONG-TERM FOLLOW-UP OF 230 ADULT PATIENTS WITH CUSHING DISEASE: A MULTICENTER RETROSPECTIVE STUDY.
Endocr Pract
; 23(8): 962-970, 2017 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-28614003
20.
A prospective study of appetite and food craving in 30 patients with Cushing's disease.
Pituitary
; 19(2): 117-26, 2016 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-26496766